Investor List:

Top BioTech Series B Investors in Midwest (71)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top BioTech investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Dave Kashen, Managing Partner at Fearless Ventures
Dave Kashen
Fearless Ventures·Managing Partner
Sweet spot: $1M
Range: $250K - $5.0M
Investors in San Francisco (CA), Investors in Palo Alto (CA), Investors in New York (NY), Investors in Los Angeles (CA), Investors in Menlo Park (CA), Investors in San Mateo (CA), Investors in Denver (CO), Investors in Detroit (MI), Investors in Ann Arbor (MI)
Investors in AR/VR (Series A), Investors in Robotics (Series A), Investors in Impact (Series A), Investors in EnergyTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Impact (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series A), Investors in EnergyTech (Series A), Investors in AR/VR (Series A), Investors in Impact (Series A), Investors in EnergyTech (Series A), Investors in Robotics (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Web3/Blockchain (Series A), Investors in Robotics (Series A), Investors in Consumer Health (Series A), Investors in Web3/Blockchain (Series A), Investors in Consumer Health (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in AR/VR (Series A), Investors in AR/VR (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Robotics (Series A), Investors in Web3/Blockchain (Series A), Investors in Consumer Health (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AR/VR (Series A), Investors in EnergyTech (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in Impact (Series A), Investors in Consumer Health (Series A), Investors in Web3/Blockchain (Series A), Investors in Impact (Series A), Investors in AR/VR (Series A), Investors in Robotics (Series A), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in Robotics (Series A), Investors in AI (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Enterprise (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Web3/Blockchain (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in Enterprise (Series A), Investors in AR/VR (Series B), Investors in Impact (Series B), Investors in Impact (Series B), Investors in AR/VR (Series B), Investors in EnergyTech (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Robotics (Series B), Investors in Impact (Series B), Investors in Web3/Blockchain (Series B), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Robotics (Series B), Investors in Consumer Health (Series B), Investors in Web3/Blockchain (Series B), Investors in Enterprise (Series B), Investors in Robotics (Series B), Investors in Consumer Health (Series B), Investors in Impact (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in EnergyTech (Series B), Investors in AI (Series B), Investors in AR/VR (Series B), Investors in AR/VR (Series B), Investors in Consumer Health (Series B), Investors in Web3/Blockchain (Series B), Investors in Robotics (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in Web3/Blockchain (Series B), Investors in AR/VR (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in EnergyTech (Series B), Investors in Impact (Series B), Investors in Enterprise (Series B), Investors in AR/VR (Series B), Investors in Impact (Series B), Investors in Robotics (Series B), Investors in Web3/Blockchain (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in EnergyTech (Series B), Investors in Robotics (Series B), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Web3/Blockchain (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Enterprise (Series B), Investors in Colorado / Utah (Other Lists), Investors in Midwest (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Dave
Photo of Michael Lavin, Managing Partner at Germin8 Ventures
Michael Lavin
Germin8 Ventures·Managing Partner
Sweet spot: $2.0M
Range: $1M - $3.0M
Investors in Global, Investors in Chicago (IL), Investors in SF Bay Area (CA), Investors in Herzliya (Israel)
Investors in Impact (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in BioTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Impact (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in AI (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in AI (Pre-seed), Investors in Impact (Pre-seed), Investors in AgTech (Pre-seed), Investors in Impact (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in AgTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Impact (Seed), Investors in Food and Beverage (Seed), Investors in AgTech (Seed), Investors in Impact (Seed), Investors in Food and Beverage (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in Food and Beverage (Seed), Investors in AgTech (Seed), Investors in Impact (Seed), Investors in Food and Beverage (Seed), Investors in Impact (Seed), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in Impact (Series A), Investors in Impact (Series A), Investors in Food and Beverage (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Food and Beverage (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in AI (Series A), Investors in Food and Beverage (Series A), Investors in AgTech (Series A), Investors in AI (Series A), Investors in Impact (Series A), Investors in Food and Beverage (Series A), Investors in AgTech (Series A), Investors in Impact (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in Food and Beverage (Series B), Investors in Impact (Series B), Investors in AgTech (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Impact (Series B), Investors in AgTech (Series B), Investors in Food and Beverage (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in AgTech (Series B), Investors in Food and Beverage (Series B), Investors in Impact (Series B), Investors in AI (Series B), Investors in Food and Beverage (Series B), Investors in AgTech (Series B), Investors in Impact (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in AI (Series B), Investors in Israel (Other Lists), Investors in Midwest (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Michael
Photo of Matt McGauley, Investor at Brickyard
Matt McGauley
Brickyard·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Chattanooga (TN)
Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Hardware (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Hardware (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Hardware (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Matt
Photo of Craig Albrecht, Managing Director at Thompson Street Capital Partners
Craig Albrecht
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Craig
Photo of Brian Sapp, Managing Director at Runway Growth Capital
Brian Sapp
Runway Growth Capital·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY), Investors in San Diego (CA), Investors in Chicago (IL)
Investors in Enterprise Infrastructure (Series B), Investors in BioTech (Series B), Investors in Enterprise Applications (Series B), Investors in Medical Devices (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in SaaS (Series B), Investors in Enterprise Infrastructure (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise Applications (Series B), Investors in FinTech (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in SaaS (Series B), Investors in FinTech (Series B), Investors in Medical Devices (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Consumer Health (Series B), Investors in SaaS (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Internet (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in Enterprise (Series B), Investors in Consumer Internet (Series B), Investors in FinTech (Series B), Investors in Midwest (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Brian
Photo of Keith Crandell, Managing Director at ARCH Venture Partners
Keith Crandell
ARCH Venture Partners·Managing Director
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Chicago (IL)
Investors in Semiconductors (Series A), Investors in Chemicals (Series A), Investors in SMB Software (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Chemicals (Series A), Investors in Semiconductors (Series A), Investors in Medical Devices (Series A), Investors in SMB Software (Series A), Investors in BioTech (Series A), Investors in Semiconductors (Series B), Investors in Chemicals (Series B), Investors in Medical Devices (Series B), Investors in SMB Software (Series B), Investors in BioTech (Series B), Investors in Chemicals (Series B), Investors in Semiconductors (Series B), Investors in Medical Devices (Series B), Investors in SMB Software (Series B), Investors in BioTech (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Keith
Photo of Chris Danforth, General Partner at Cultivation Capital
Chris Danforth
Cultivation Capital·General Partner
Sweet spot: $1.8M
Range: $100K - $3.5M
Investors in St. Louis (MO)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Midwest (Other Lists)
to see your intro paths to Chris
Photo of William Schmidt, General Partner at Cultivation Capital
William Schmidt
Cultivation Capital·General Partner
Sweet spot: $1.8M
Range: $100K - $3.5M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists)
to see your intro paths to William
Get new data & insights delivered to your inbox
Firms investing in this space